Close

Alnylam Pharma (ALNY) Receives U.S. Patent '262 NoA Covering siRNA Molecules

August 20, 2014 8:07 AM EDT Send to a Friend
Alnylam Pharma (Nasdaq: ALNY) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login